These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20124755)

  • 21. Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells.
    Brignole-Baudouin F; Riancho L; Liang H; Baudouin C
    Curr Eye Res; 2011 Nov; 36(11):979-88. PubMed ID: 21999224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicity evaluation of antiglaucoma drugs using stratified human cultivated corneal epithelial sheets.
    Nakagawa S; Usui T; Yokoo S; Omichi S; Kimakura M; Mori Y; Miyata K; Aihara M; Amano S; Araie M
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5154-60. PubMed ID: 22695966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of Glaucoma Medications on Corneal Wound Healing.
    Pinheiro R; Panfil C; Schrage N; Dutescu RM
    J Glaucoma; 2016 Jan; 25(1):122-7. PubMed ID: 26164144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficiency of instillation methods for prostaglandin medications.
    Fiscella R; Wilensky JT; Chiang TH; Walt JG
    J Ocul Pharmacol Ther; 2006 Dec; 22(6):477-82. PubMed ID: 17238816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corneal punctate staining with latanoprost, bimatoprost, and travoprost in healthy subjects.
    Stewart WC; Stewart JA; Jenkins JN; Jackson AL
    J Glaucoma; 2003 Dec; 12(6):475-9. PubMed ID: 14646682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Considerations about administration angle of prostaglandin analogs].
    Estacia P; Tognon T
    Arq Bras Oftalmol; 2008; 71(5):684-8. PubMed ID: 19039464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system.
    Liang H; Pauly A; Riancho L; Baudouin C; Brignole-Baudouin F
    Br J Ophthalmol; 2011 Jun; 95(6):869-75. PubMed ID: 21429894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.
    Ota T; Aihara M; Narumiya S; Araie M
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4159-63. PubMed ID: 16249494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost.
    Aihara M; Otani S; Kozaki J; Unoki K; Takeuchi M; Minami K; Miyata K
    J Glaucoma; 2012 Jan; 21(1):60-4. PubMed ID: 21278589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Topouzis F; Melamed S; Danesh-Meyer H; Wells AP; Kozobolis V; Wieland H; Andrew R; Wells D
    Eur J Ophthalmol; 2007; 17(2):183-90. PubMed ID: 17415690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the effect of benzalkonium chloride-preserved, polyquad-preserved, and preservative-free prostaglandin analogue eye drops on cultured human conjunctival goblet cells.
    Hedengran A; Freiberg J; May Hansen P; Boix-Lemonche G; Utheim TP; Dartt DA; Petrovski G; Heegaard S; Kolko M
    J Optom; 2024; 17(1):100481. PubMed ID: 37788596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human cornea epithelial cell culture system.
    Yee RW; Norcom EG; Zhao XC
    Adv Ther; 2006; 23(4):511-9. PubMed ID: 17050493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
    Ota T; Murata H; Sugimoto E; Aihara M; Araie M
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2006-11. PubMed ID: 15914616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corneal epithelial cell viability following exposure to ophthalmic solutions containing preservatives and/or antihypertensive agents.
    Whitson JT; Petroll WM
    Adv Ther; 2012 Oct; 29(10):874-88. PubMed ID: 23065664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraocular pressure control with latanoprost/timolol and travoprost/timolol fixed combinations : a retrospective, multicentre, cross-sectional study.
    Denis P; Lafuma A; Jeanbat V; Laurendeau C; Berdeaux G
    Clin Drug Investig; 2008; 28(12):767-76. PubMed ID: 18991470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of different dose schedules of latanoprost on intraocular pressure and pupil size in the glaucomatous Beagle.
    Gelatt KN; MacKay EO
    Vet Ophthalmol; 2001 Dec; 4(4):283-8. PubMed ID: 11906665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
    Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.
    Nagai N; Ito Y; Okamoto N; Shimomura Y
    Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure.
    Dubiner HB; Sircy MD; Landry T; Bergamini MV; Silver LH; Darell Turner F; Robertson S; Andrew RM; Weiner A; Przydryga J
    Clin Ther; 2004 Jan; 26(1):84-91. PubMed ID: 14996520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells.
    Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2444-50. PubMed ID: 15980234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.